A phase III, randomised, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anaemia and non-dialysis-dependent chronic kidney disease

Type of Cancer
Renal Cancer

Site
Bethesda

Protocol Number
P-MONOFER-CKD-04

To Learn More Call
201-510-0910